Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avita Medical (RCEL)
NASDAQ:RCEL
Holding RCEL?
Track your performance easily
RCEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.51 - $18.93
Previous Close$13.34
Volume143.46K
Average Volume (3M)101.17K
Market Cap
$349.74M
Enterprise Value$350.96M
Total Cash (Recent Filing)$44.41M
Total Debt (Recent Filing)$45.63M
Price to Earnings (P/E)―
Beta2.12
Next Earnings
Feb 20, 2025EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.23
Shares Outstanding26,217,629
10 Day Avg. Volume143,751
30 Day Avg. Volume101,174
Standard Deviation0.20
R-Squared0.17
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)27.77
Price to Sales (P/S)5.66
Price to Cash Flow (P/CF)-11.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.85
Enterprise Value/Gross Profit8.28
Enterprise Value/Ebitda-6.86
Forecast
1Y Price Target
$15.67Price Target Upside17.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Avita Medical News
PremiumCompany Announcements
Avita Medical Reports Strong Q3 Revenue Growth
Bulls Say, Bears Say
Bulls Say
Commercial SuccessRECELL GO Adoption and Utilization Helped Drive Record Commercial Sales in 3Q.
Product Portfolio ExpansionAvita is actively expanding its portfolio through distribution/co-development agreements and new products.
Revenue GrowthAvita's flagship RECELL platform is generating nice traction, as evidenced by the 29% revenue growth performance.
Bears Say
Company ChallengesThis is the third guidance reduction this year, reflecting ongoing challenges in the company's launch.
Financial PerformanceThe company is lowering its guidance to $68.0M-$70.0M, down from $78.5M-$84.5M previously.
Growth MetricsAccount growth is still tracking below initial expectations, indicating slower-than-anticipated progress.
---
Ownership Overview
1.15% Insiders
8.52% Mutual Funds
1.89% Other Institutional Investors
79.04% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RCEL FAQ
What was Avita Medical’s price range in the past 12 months?
Avita Medical lowest stock price was $7.51 and its highest was $18.93 in the past 12 months.
What is Avita Medical’s market cap?
Currently, no data Available
When is Avita Medical’s upcoming earnings report date?
Avita Medical’s upcoming earnings report date is Feb 20, 2025 which is in 85 days.
How were Avita Medical’s earnings last quarter?
Avita Medical released its earnings results on Nov 07, 2024. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.434 by -$0.186.
Is Avita Medical overvalued?
According to Wall Street analysts Avita Medical’s price is currently Undervalued.
Does Avita Medical pay dividends?
Avita Medical does not currently pay dividends.
What is Avita Medical’s EPS estimate?
Avita Medical’s EPS estimate is -$0.36.
How many shares outstanding does Avita Medical have?
Avita Medical has 26,217,628 shares outstanding.
What happened to Avita Medical’s price movement after its last earnings report?
Avita Medical reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.434. Following the earnings report the stock price went down -3.629%.
Which hedge fund is a major shareholder of Avita Medical?
Among the largest hedge funds holding Avita Medical’s share is Hussman Strategic Advisors Inc. It holds Avita Medical’s shares valued at N/A.
---
Avita Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.67 (17.47% Upside)
$15.67 (17.47% Upside)
Blogger Sentiment
Bullish
RCEL Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 42.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.0%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.04%
12-Months-Change
Fundamentals
Return on Equity
-152.44%
Trailing 12-Months
Asset Growth
0.05%
Trailing 12-Months
Company Description
Avita Medical
Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company was founded on December 21, 1992 and is headquartered in Royston, the United Kingdom.
---
RCEL Company Deck
---
RCEL Earnings Call
Q3 2024
0:00 / 0:00
---
RCEL Revenue Breakdown
99.27% Commercial sales
0.67% Services for emergency preparedness
0.07% Deferred commercial revenue
---
RCEL Stock 12 Month Forecast
Average Price Target
$15.67
▲(17.47% Upside)
Technical Analysis
Best Analysts Covering RCEL
1 Year
1 Year Success Rate
8/19 ratings generated profit
1 Year Average Return
-7.04%
reiterated a buy rating 19 days ago
Copying Brooks O'Neil's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -7.04% per trade.
---